NAUT Nautilus Biotechnology, Inc. Stock Quote

NAUT [NASD]

Index	-	P/E	-	EPS (ttm)	-0.46	Insider Own	8.00%	Shs Outstand	124.42M	Perf Week	-10.83%
Market Cap	345.10M	Forward P/E	-	EPS next Y	-0.90	Insider Trans	1.03%	Shs Float	90.31M	Perf Month	-18.94%
Income	-57.70M	PEG	-	EPS next Q	-0.17	Inst Own	45.30%	Short Float	2.40%	Perf Quarter	-34.76%
Sales	-	P/S	-	EPS this Y	-221.60%	Inst Trans	27.95%	Short Ratio	5.79	Perf Half Y	-53.64%
Book/sh	2.81	P/B	0.95	EPS next Y	-30.90%	ROA	-14.80%	Target Price	8.00	Perf Year	-73.28%
Cash/sh	2.51	P/C	1.06	EPS next 5Y	-	ROE	-15.60%	52W Range	2.55 - 12.38	Perf YTD	-48.36%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-78.39%	Beta	-
Dividend %	-	Quick Ratio	51.10	Sales past 5Y	-	Gross Margin	-	52W Low	4.90%	ATR	0.26
Employees	113	Current Ratio	51.10	Sales Q/Q	-	Oper. Margin	-	RSI (14)	35.67	Volatility	10.75% 8.65%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-87.00%	Profit Margin	-	Rel Volume	0.43	Prev Close	2.77
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 03 BMO	Payout	-	Avg Volume	374.87K	Price	2.67
Recom	2.20	SMA20	-16.31%	SMA50	-27.01%	SMA200	-41.91%	Volume	162,251	Change	-3.43%

Jan-06-22

Initiated

Morgan Stanley

Equal-Weight

Nov-02-21

Initiated

Cowen

Outperform

Aug-04-21

Initiated

Goldman

Neutral

$10

Jul-13-21

Initiated

Jefferies

Buy

$13

May-12-22 06:28AM	Trade Alert: The Co-Founder Of Nautilus Biotechnology, Inc. (NASDAQ:NAUT), Sujal Patel, Has Just Spent US$198k Buying A Few More Shares Simply Wall St. +6.81%
May-03-22 06:00AM	Nautilus Biotechnology Reports First Quarter 2022 Financial Results GlobeNewswire
Apr-12-22 08:00AM	Nautilus Biotechnology Appoints Gwen Weld as Chief People Officer and Sheri Wilcox, Ph.D., as Vice President of Affinity Reagent Development GlobeNewswire
Apr-07-22 08:00AM	Nautilus Biotechnology to Announce First Quarter 2022 Financial Results on May 3, 2022 GlobeNewswire
Apr-04-22 08:00AM	Nautilus Biotechnology to Present at EuPA and AACR Meetings GlobeNewswire
Mar-31-22 04:05PM	Nautilus Biotechnology Appoints Karen Akinsanya, Ph.D., to Board of Directors GlobeNewswire
Mar-05-22 07:22AM	What Percentage Of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Shares Do Insiders Own? Simply Wall St.
Feb-24-22 06:00AM	Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2021 Financial Results GlobeNewswire +8.43%
Feb-16-22 04:05PM	Nautilus to Participate in the 42nd Annual Cowen Health Care Conference GlobeNewswire
Feb-02-22 01:38PM	Clarius Group, LLC Buys BTC BlackRock Ultra Short-Term Bond ETF, , Vanguard Ultra-Short Bond ... GuruFocus.com
Jan-27-22 08:00AM	Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022 GlobeNewswire -6.75%
Dec-16-21 01:07PM	A look at insider stock sales among Portland-area companies in 2021 (Photos) American City Business Journals
Dec-05-21 06:39AM	Insider Buying: The Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Co-Founder Just Bought 1.5% More Shares Simply Wall St.
Nov-02-21 08:00AM	Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome GlobeNewswire +7.17%
08:00AM	Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome CNW Group
06:00AM	Nautilus Biotechnology Reports Third Quarter 2021 Financial Results GlobeNewswire
Oct-11-21 08:00AM	Nautilus Biotechnology to Announce Third Quarter of Fiscal Year 2021 Financial Results on November 2, 2021 GlobeNewswire
Sep-10-21 10:21AM	Do Insiders Own Lots Of Shares In Nautilus Biotechnology, Inc. (NASDAQ:NAUT)? Simply Wall St.
Sep-03-21 09:00AM	Nautilus to Participate in the Morgan Stanley Global Healthcare Conference GlobeNewswire
Aug-10-21 06:00AM	Nautilus Biotechnology Reports Second Quarter 2021 Financial Results GlobeNewswire -5.01%
Aug-09-21 08:00AM	Nautilus Biotechnology Appoints Karl Voss, Ph.D., as Vice President of Life Sciences Research and Development GlobeNewswire +6.68%
Jul-13-21 08:00AM	Nautilus Biotechnology to Announce Second Quarter of Fiscal Year 2021 Financial Results on August 10, 2021 GlobeNewswire
Jun-17-21 07:00AM	Nautilus Biotechnology Appoints Emma Lundberg, Ph.D., to Scientific Advisory Board GlobeNewswire

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mowry Anna	CFO and Treasurer	Jun 27	Buy	2.75	5,500	15,124	39,250	Jun 28 06:17 PM
Patel Sujal M	CEO, President, and Secretary	May 09	Buy	3.96	50,000	198,000	9,964,488	May 10 08:28 PM
Patel Sujal M	CEO, President, and Secretary	Mar 04	Option Exercise	10.00	100	1,000	9,914,488	Mar 04 05:39 PM
Patel Sujal M	CEO, President, and Secretary	Mar 03	Buy	3.60	50,000	179,890	9,914,388	Mar 04 05:39 PM
PERCEPTIVE ADVISORS LLC	Director	Dec 08	Buy	5.36	200,000	1,072,000	9,111,151	Dec 10 04:05 PM
Posard Matthew L.	Director	Dec 01	Buy	4.47	30,000	134,105	50,000	Dec 01 09:41 PM
Patel Sujal M	CEO, President, and Secretary	Dec 01	Buy	4.73	88,022	416,397	9,864,388	Dec 02 08:49 AM
Patel Sujal M	CEO, President, and Secretary	Nov 30	Buy	4.72	161,978	764,779	9,776,366	Dec 02 08:49 AM
Posard Matthew L.	Director	Nov 30	Buy	4.57	20,000	91,400	20,000	Dec 01 09:41 PM
Mowry Anna	CFO and Treasurer	Nov 24	Buy	4.58	15,000	68,632	32,500	Nov 24 05:12 PM
McIlwain Matthew S	Director	Nov 15	Buy	5.30	100,000	529,890	459,075	Nov 17 08:19 PM
McIlwain Matthew S	Director	Aug 26	Buy	7.71	11,709	90,314	359,075	Aug 26 07:29 PM
McIlwain Matthew S	Director	Aug 25	Buy	7.74	11,693	90,458	347,366	Aug 26 07:29 PM
McIlwain Matthew S	Director	Aug 24	Buy	7.68	13,568	104,269	335,673	Aug 26 07:29 PM
Murphy Matthew B.	General Counsel	Aug 13	Buy	7.56	5,000	37,806	34,140	Aug 13 09:01 PM
Mowry Anna	CFO and Treasurer	Aug 12	Buy	7.71	17,500	134,925	17,500	Aug 16 05:12 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience